Advarra, a provider of regulatory review solutions and clinical research technology, has launched Oncology Research Pulse, a new content-driven, thought leadership initiative designed to foster collaboration among clinical trial sponsors, study sites, contract research organizations (CROs), patient advocates, and other key stakeholders across the research community. This initiative will serve as a platform for expert insights, meaningful dialogue, and the exchange of best practices to support the advancement of oncology clinical trials.

“Cancer research is evolving at an unprecedented pace. New therapies, shifting regulations, and cutting-edge technologies are transforming how trials are designed and conducted. Yet, persistent challenges remain—study startup is too slow, research sites are overburdened, and too many patients struggle to access innovative treatments,” said Christine Senn, PhD, Senior Vice President and Head of Site-Sponsor Innovation at Advarra. “Advarra has long been committed to optimizing cancer trials—making them faster, more efficient, compliant, and ethical. Oncology Research Pulse is an extension of this commitment, bringing together key stakeholders, to facilitate conversations that drive meaningful progress in the execution of cancer studies.”

Oncology Research Pulse will explore scientific advancements in treatment strategies, evolving trial methodologies, and the role of technology and other novel solutions in optimizing study design, regulatory compliance, and operational feasibility. The program will also address opportunities to improve diversity in clinical trials and foster equitable and inclusive research programs that reflect the populations they serve.

As part of this initiative, Advarra is partnering with Fierce Pharma on a webinar series, convening thought leaders from across the research community to discuss critical issues shaping the future of oncology trials. Oncology Research Pulse will also cover key updates from major oncology-focused conferences throughout the year.